Cargando…
Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume
Molecular tumor volume (MTV) is a parameter of interest in prostate cancer for assessing total disease burden on prostate-specific membrane antigen (PSMA) PET. Although software segmentation tools can delineate whole-body MTV, a necessary step toward meaningful monitoring of total tumor burden and t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051594/ https://www.ncbi.nlm.nih.gov/pubmed/34446454 http://dx.doi.org/10.2967/jnumed.121.262528 |
_version_ | 1784696594039308288 |
---|---|
author | Seifert, Robert Sandach, Patrick Kersting, David Fendler, Wolfgang P. Hadaschik, Boris Herrmann, Ken Sunderland, John J. Pollard, Janet H. |
author_facet | Seifert, Robert Sandach, Patrick Kersting, David Fendler, Wolfgang P. Hadaschik, Boris Herrmann, Ken Sunderland, John J. Pollard, Janet H. |
author_sort | Seifert, Robert |
collection | PubMed |
description | Molecular tumor volume (MTV) is a parameter of interest in prostate cancer for assessing total disease burden on prostate-specific membrane antigen (PSMA) PET. Although software segmentation tools can delineate whole-body MTV, a necessary step toward meaningful monitoring of total tumor burden and treatment response through PET is establishing the repeatability of these metrics. The present study assessed the repeatability of total MTV and related metrics for (68)Ga-PSMA-HBED-CC in prostate cancer. Methods: Eighteen patients from a prior repeatability study who underwent 2 test–retest PSMA PET/CT scans within a mean interval of 5 d were reanalyzed. Within-subject coefficient of variation and repeatability coefficients (RCs) were analyzed on a per-lesion and per-patient basis. For the per-lesion analysis, individual lesions were segmented for analysis by a single reader. For the per-patient analysis, subgroups of up to 10 lesions (single reader) and the total tumor volume per patient were segmented (independently by 2 readers). Image parameters were MTV, SUV(max), SUV(peak), SUV(mean), total lesion PSMA, and the related metric PSMA quotient (which integrates lesion volume and PSMA avidity). Results: In total, 192 segmentations were analyzed for the per-lesion analysis and 1,662 segmentations for the per-patient analysis (combining the 2 readers and 2 scans). The RC of the MTV of single lesions was 77% (95% CI, 63%–96%). The RC improved to 33% after aggregation of up to 10 manually selected lesions into subgroups assessed per patient (95% CI, 25%–46%). The RC of the semiautomatic MTV(total) (the sum of all voxels in the whole-body total tumor segmentation per patient) was 35% (95% CI, 25%–50%), the Bland-Altman bias was −6.70 (95% CI, −14.32–0.93). Alternating readers between scans led to a comparable RC of 37% (95% CI, 28%–49%) for MTV(total), meaning that the metric is robust between scanning sessions and between readers. Conclusion: (68)Ga-PSMA-HBED-CC PET–derived semiautomatic MTV(total) is repeatable and reader-independent, with a change of ±35% representing a true change in tumor volume. Volumetry of single manually selected lesions has considerably lower repeatability, and volumetry based on subgroups of these lesions, although showing acceptable repeatability, is less systematic. The semiautomatic analysis of MTV(total) used in this study offers an efficient and robust means of assessing response to therapy. |
format | Online Article Text |
id | pubmed-9051594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Society of Nuclear Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-90515942022-05-17 Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume Seifert, Robert Sandach, Patrick Kersting, David Fendler, Wolfgang P. Hadaschik, Boris Herrmann, Ken Sunderland, John J. Pollard, Janet H. J Nucl Med Basic Science Investigation Molecular tumor volume (MTV) is a parameter of interest in prostate cancer for assessing total disease burden on prostate-specific membrane antigen (PSMA) PET. Although software segmentation tools can delineate whole-body MTV, a necessary step toward meaningful monitoring of total tumor burden and treatment response through PET is establishing the repeatability of these metrics. The present study assessed the repeatability of total MTV and related metrics for (68)Ga-PSMA-HBED-CC in prostate cancer. Methods: Eighteen patients from a prior repeatability study who underwent 2 test–retest PSMA PET/CT scans within a mean interval of 5 d were reanalyzed. Within-subject coefficient of variation and repeatability coefficients (RCs) were analyzed on a per-lesion and per-patient basis. For the per-lesion analysis, individual lesions were segmented for analysis by a single reader. For the per-patient analysis, subgroups of up to 10 lesions (single reader) and the total tumor volume per patient were segmented (independently by 2 readers). Image parameters were MTV, SUV(max), SUV(peak), SUV(mean), total lesion PSMA, and the related metric PSMA quotient (which integrates lesion volume and PSMA avidity). Results: In total, 192 segmentations were analyzed for the per-lesion analysis and 1,662 segmentations for the per-patient analysis (combining the 2 readers and 2 scans). The RC of the MTV of single lesions was 77% (95% CI, 63%–96%). The RC improved to 33% after aggregation of up to 10 manually selected lesions into subgroups assessed per patient (95% CI, 25%–46%). The RC of the semiautomatic MTV(total) (the sum of all voxels in the whole-body total tumor segmentation per patient) was 35% (95% CI, 25%–50%), the Bland-Altman bias was −6.70 (95% CI, −14.32–0.93). Alternating readers between scans led to a comparable RC of 37% (95% CI, 28%–49%) for MTV(total), meaning that the metric is robust between scanning sessions and between readers. Conclusion: (68)Ga-PSMA-HBED-CC PET–derived semiautomatic MTV(total) is repeatable and reader-independent, with a change of ±35% representing a true change in tumor volume. Volumetry of single manually selected lesions has considerably lower repeatability, and volumetry based on subgroups of these lesions, although showing acceptable repeatability, is less systematic. The semiautomatic analysis of MTV(total) used in this study offers an efficient and robust means of assessing response to therapy. Society of Nuclear Medicine 2022-05 /pmc/articles/PMC9051594/ /pubmed/34446454 http://dx.doi.org/10.2967/jnumed.121.262528 Text en © 2022 by the Society of Nuclear Medicine and Molecular Imaging. https://creativecommons.org/licenses/by/4.0/Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml. |
spellingShingle | Basic Science Investigation Seifert, Robert Sandach, Patrick Kersting, David Fendler, Wolfgang P. Hadaschik, Boris Herrmann, Ken Sunderland, John J. Pollard, Janet H. Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume |
title | Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume |
title_full | Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume |
title_fullStr | Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume |
title_full_unstemmed | Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume |
title_short | Repeatability of (68)Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume |
title_sort | repeatability of (68)ga-psma-hbed-cc pet/ct–derived total molecular tumor volume |
topic | Basic Science Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051594/ https://www.ncbi.nlm.nih.gov/pubmed/34446454 http://dx.doi.org/10.2967/jnumed.121.262528 |
work_keys_str_mv | AT seifertrobert repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT sandachpatrick repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT kerstingdavid repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT fendlerwolfgangp repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT hadaschikboris repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT herrmannken repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT sunderlandjohnj repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume AT pollardjaneth repeatabilityof68gapsmahbedccpetctderivedtotalmoleculartumorvolume |